Reference health

Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC

https://doi.org/10.1186/1478-811x-9-12
CiteStamped reference-health badge
124/124 checkable references clean · checked 2026-07-23

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

19 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 124 checked references that resolve
resolves10.1016/j.tibtech.2006.01.010
Fat tissue: an underappreciated source of stem cells for biotechnology
resolves10.1016/S0140-6736(05)66916-4
Stem cells of the alveolar epithelium
resolves10.1016/S0092-8674(03)00687-1
Adult Cardiac Stem Cells Are Multipotent and Support Myocardial Regeneration
resolves10.1126/science.284.5411.143
Multilineage Potential of Adult Human Mesenchymal Stem Cells
resolves10.1007/10_2009_24
Isolation, Characterization, Differentiation, and Application of Adipose-Derived Stem Cells
resolves10.1038/sj.bmt.1705358
Isolation of mesenchymal stem cells from G-CSF-mobilized human peripheral blood using fibrin microbeads
resolves10.1002/jor.20119
Allogenic peripheral blood derived mesenchymal stem cells (MSCs) enhance bone regeneration in rabbit ulna critical-sized bone defect model
resolves10.1080/14653240600855905
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
resolves10.1089/scd.2009.0299
New Emerging Potentials for Human Wharton’s Jelly Mesenchymal Stem Cells: Immunological Features and Hepatocyte-Like Differentiative Capacity
resolves10.1634/stemcells.2006-0589
Concise Review: Adipose Tissue-Derived Stromal Cells—Basic and Clinical Implications for Novel Cell-Based Therapies
resolves10.1016/S0165-2478(03)00108-1
Differential expression of stem cell mobilization-associated molecules on multi-lineage cells from adipose tissue and bone marrow
resolves10.1091/mbc.E02-02-0105
Human Adipose Tissue Is a Source of Multipotent Stem Cells
resolves10.1634/stemcells.2004-0330
Mesenchymal Stem Cells Derived from CD133‐Positive Cells in Mobilized Peripheral Blood and Cord Blood: Proliferation, Oct4 Expression, and Plasticity
resolves10.1089/scd.2007.0154
Comparison of Human Placenta- and Bone Marrow–Derived Multipotent Mesenchymal Stem Cells
resolves10.1634/stemcells.2004-0058
Isolation of Mesenchymal Stem Cells of Fetal or Maternal Origin from Human Placenta
resolves10.1089/scd.2007.0156
Molecular Trafficking Mechanisms of Multipotent Mesenchymal Stem Cells Derived from Human Bone Marrow and Placenta
resolves10.1634/stemcells.2007-0594
Concise Review: Isolation and Characterization of Cells from Human Term Placenta: Outcome of the First International Workshop on Placenta Derived Stem Cells
resolves10.1111/j.1432-0436.2007.00194.x
Isolation, characterization, and differentiation of stem cells derived from the rat amniotic membrane
resolves10.1634/stemcells.2004-0357
Stem Cell Characteristics of Amniotic Epithelial Cells
resolves10.1111/j.1749-0774.2007.00032.x
Differentiation of mesenchymal cells derived from human amniotic membranes into hepatocyte-like cells in vitro
resolves10.1016/j.ajog.2006.01.101
Placental mesenchymal stem cells as potential autologous graft for pre- and perinatal neuroregeneration
resolves10.1002/term.40
Isolation and characterization of mesenchymal cells from human fetal membranes
resolves10.1016/j.bbrc.2007.03.157
Placenta-derived multipotent stem cells induced to differentiate into insulin-positive cells
resolves10.1634/stemcells.22-5-649
Human Placenta‐Derived Cells Have Mesenchymal Stem/Progenitor Cell Potential
resolves10.1080/14653240410005366-1
Isolation and characterization of mesenchymal progenitor cells from chorionic villi of human placenta
resolves10.1016/j.yexcr.2007.04.028
‘Working’ cardiomyocytes exhibiting plateau action potentials from human placenta-derived extraembryonic mesodermal cells
resolves10.1016/j.ajog.2010.06.045
Isolation and characterization of true mesenchymal stem cells derived from human term decidua capable of multilineage differentiation into all 3 embryonic layers
resolves10.1038/nbt1274
Isolation of amniotic stem cell lines with potential for therapy
resolves10.1186/1479-5876-5-57
Endometrial regenerative cells: A novel stem cell population
resolves10.1186/1478-811X-7-S1-A6
An atypical NF-kappa B-regulated pathway mediates phorbol ester-dependent Heme oxygenase-1 gene activation in monocytes
resolves10.1634/stemcells.2007-0417
Concise Review: Human Umbilical Cord Stroma with Regard to the Source of Fetus-Derived Stem Cells
resolves10.1016/S0091-679X(08)00007-1
Isolation, Characterization, and Differentiation of Human Umbilical Cord Perivascular Cells (HUCPVCs)
resolves10.1007/s12015-010-9165-y
Growth and Differentiation Properties of Mesenchymal Stromal Cell Populations Derived from Whole Human Umbilical Cord
resolves10.1634/stemcells.2006-0286
Biology of Stem Cells in Human Umbilical Cord Stroma: In Situ and In Vitro Surveys
resolves10.1634/stemcells.2004-0166
Human Umbilical Cord Perivascular (HUCPV) Cells: A Source of Mesenchymal Progenitors
resolves10.1634/stemcells.2004-0013
Mesenchymal Stem Cells in the Wharton's Jelly of the Human Umbilical Cord
resolves10.1016/S0076-6879(06)19018-7
Cord Blood Stem and Progenitor Cells
resolves10.1016/S0301-472X(02)00805-6
Ex vivo expanded cord blood cells provide rapid engraftment in fetal sheep but lack long-term engrafting potential
resolves10.1186/1477-5956-8-18
Proteome analysis of human Wharton's jelly cells during in vitro expansion
resolves10.2217/rme.10.98
Musculoskeletal Tissue Engineering with Human Umbilical Cord mesenchymal Stromal Cells
resolves10.1111/j.1582-4934.2004.tb00320.x
Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy
resolves10.1634/stemcells.2006-0709
Comparison of Proliferative and Multilineage Differentiation Potential of Human Mesenchymal Stem Cells Derived from Umbilical Cord and Bone Marrow
resolves10.1089/ten.tea.2008.0579
Differentiation of Wharton's Jelly Primitive Stromal Cells into Insulin-Producing Cells in Comparison with Bone Marrow Mesenchymal Stem Cells
resolves10.1016/j.exphem.2009.02.003
Endothelial differentiation of Wharton's jelly–derived mesenchymal stem cells in comparison with bone marrow–derived mesenchymal stem cells
resolves10.1634/stemcells.2005-0342
Comparative Analysis of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood, or Adipose Tissue
resolves10.1089/scd.2007.0217
Comparative Analysis of Mesenchymal Stem Cells from Bone Marrow, Cartilage, and Adipose Tissue
resolves10.1097/01.prs.0000185606.03222.a9
The Osteogenic Potential of Adipose-Derived Mesenchymal Cells Is Maintained with Aging
resolves10.1097/SAP.0b013e3181723bbe
Regional Anatomic and Age Effects on Cell Function of Human Adipose-Derived Stem Cells
resolves10.1016/j.metabol.2003.11.012
Comparison of proliferation and differentiation capacity of human adipocyte precursor cells from the omental and subcutaneous adipose tissue depot of obese subjects
resolves10.1007/s00418-008-0519-3
Isolation and characterization of Oct-4+/HLA-G+ mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers
resolves10.1634/stemcells.2005-0330
Human Umbilical Cord Matrix Stem Cells: Preliminary Characterization and Effect of Transplantation in a Rodent Model of Parkinson's Disease
resolves10.1634/stemcells.21-1-50
Matrix Cells from Wharton's Jelly Form Neurons and Glia
resolves10.1532/IJH97.07041
Mesenchymal Stem Cells for the Treatment of Heart Failure
resolves10.1038/ncpcardio0444
Plasticity of human adipose stem cells toward endothelial cells and cardiomyocytes
resolves10.1007/BF02256131
Transformation of human umbilical mesenchymal cells into neurons in vitro
resolves10.1634/stemcells.2005-0053
Conversion of Human Umbilical Cord Mesenchymal Stem Cells in Wharton's Jelly to Dopaminergic Neurons In Vitro: Potential Therapeutic Application for Parkinsonism
resolves10.1016/S1534-5807(04)00075-9
Cell Shape, Cytoskeletal Tension, and RhoA Regulate Stem Cell Lineage Commitment
resolves10.1073/pnas.76.10.5138
A study of the adipose conversion of suspended 3T3 cells by using glycerophosphate dehydrogenase as differentiation marker
resolves10.1016/j.bbrc.2007.05.070
Fibroblast growth factor-2 stimulates adipogenic differentiation of human adipose-derived stem cells
resolves10.2337/diabetes.47.4.507
PPAR-gamma: adipogenic regulator and thiazolidinedione receptor.
resolves10.1089/ten.2006.0317
17-β Estradiol Enhances Osteogenic and Adipogenic Differentiation of Human Adipose-Derived Stromal Cells
resolves10.1089/ten.tea.2008.0402
Umbilical Cord Wharton's Jelly: A New Potential Cell Source of Mesenchymal Stromal Cells for Bone Tissue Engineering
resolves10.1089/10763270360728215
Effects of Transforming Growth Factor <i>β</i> 1 and Dexamethasone on the Growth and Chondrogenic Differentiation of Adipose-Derived Stromal Cells
resolves10.1080/08977190802105917
Adenovirus-mediated expression of growth and differentiation factor-5 promotes chondrogenesis of adipose stem cells
resolves10.1016/j.bbrc.2006.02.171
Mitogenic and chondrogenic effects of fibroblast growth factor-2 in adipose-derived mesenchymal cells
resolves10.1002/jcp.20808
Extended passaging, but not aldehyde dehydrogenase activity, increases the chondrogenic potential of human adipose‐derived adult stem cells
resolves10.1089/107632701300062859
Multilineage Cells from Human Adipose Tissue: Implications for Cell-Based Therapies
resolves10.1089/107632701753337681
Extracellular Matrix Mineralization and Osteoblast Gene Expression by Human Adipose Tissue–Derived Stromal Cells
resolves10.1089/ten.2006.12.2031
Functions of Vitamin D, Retinoic Acid, and Dexamethasone in Mouse Adipose-Derived Mesenchymal Cells
resolves10.1007/s10517-009-0548-5
Effect of Dexamethasone on Differentiation of Multipotent Stromal Cells from Human Adipose Tissue
resolves10.1016/S0736-0266(02)00238-3
Bone induction by <i>BMP‐2</i> transduced stem cells derived from human fat
resolves10.1080/14653240510027244
In vitro and in vivo induction of bone formation based on ex vivo gene therapy using rat adipose-derived adult stem cells expressing BMP-7
resolves10.1515/BC.2008.031
Cellular responses to reactive oxygen species-induced DNA damage and aging
resolves10.1016/j.bbrc.2007.05.054
Hypoxia enhances proliferation and tissue formation of human mesenchymal stem cells
resolves10.1002/jcp.21987
Ex vivo expansion of human mesenchymal stem cells: A more effective cell proliferation kinetics and metabolism under hypoxia
resolves10.1089/ten.teb.2009.0825
Different Facets of Aging in Human Mesenchymal Stem Cells
resolves10.1634/stemcells.2007-1104
Hypoxic Preconditioning Results in Increased Motility and Improved Therapeutic Potential of Human Mesenchymal Stem Cells
resolves10.1016/j.stem.2010.07.007
Oxygen in Stem Cell Biology: A Critical Component of the Stem Cell Niche
resolves10.1089/ten.2006.0325
Prolonged Hypoxia Concomitant with Serum Deprivation Induces Massive Human Mesenchymal Stem Cell Death
resolves10.2217/17460751.3.6.817
Transcriptome Alterations Due to Physiological Normoxic (2% O <sub>2</sub> ) Culture of Human Embryonic Stem Cells
resolves10.1152/ajpcell.00415.2005
Effect of reduced oxygen tension on chondrogenesis and osteogenesis in adipose-derived mesenchymal cells
resolves10.3727/096368909X478560
Enhanced Chondrogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells in Low Oxygen Environment Micropellet Cultures
resolves10.1186/1478-811X-8-18
Effects of hypoxic culture conditions on umbilical cord-derived human mesenchymal stem cells
resolves10.1089/ten.teb.2009.0296
The Role of Hypoxia in Bone Marrow–Derived Mesenchymal Stem Cells: Considerations for Regenerative Medicine Approaches
resolves10.1089/scd.2009.0447
Hypoxia Responsive Mesenchymal Stem Cells Derived from Human Umbilical Cord Blood Are Effective for Bone Repair
resolves10.1002/eji.200738129
IFN‐γ activation of mesenchymal stem cells for treatment and prevention of graft <i>versus</i> host disease
resolves10.1111/j.1600-6143.2009.02721.x
Infusion of Mesenchymal Stem Cells and Rapamycin Synergize to Attenuate Alloimmune Responses and Promote Cardiac Allograft Tolerance
resolves10.4049/jimmunol.181.6.3933
Pretransplant Infusion of Mesenchymal Stem Cells Prolongs the Survival of a Semiallogeneic Heart Transplant through the Generation of Regulatory T Cells
resolves10.1016/j.trim.2008.08.004
Mesenchymal stem cells can induce long-term acceptance of solid organ allografts in synergy with low-dose mycophenolate
resolves10.1016/S0301-472X(01)00769-X
Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo
resolves10.1016/S0140-6736(04)16104-7
Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells
resolves10.1016/S0140-6736(08)60690-X
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study
resolves10.1182/blood-2005-11-011650
Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting
resolves10.1002/stem.118
Species Variation in the Mechanisms of Mesenchymal Stem Cell-Mediated Immunosuppression
resolves10.1080/14653240802582075
Human mesenchymal stromal cells from adult and neonatal sources: comparative analysis of their morphology, immunophenotype, differentiation patterns and neural protein expression
resolves10.1042/CBI20090414
The umbilical cord matrix is a better source of mesenchymal stem cells (MSC) than the umbilical cord blood
resolves10.1089/ten.tec.2010.0406
Optimization of Culture Conditions for the Expansion of Umbilical Cord-Derived Mesenchymal Stem or Stromal Cell-Like Cells Using Xeno-Free Culture Conditions
resolves10.1002/(SICI)1097-4652(199603)166:3<585::AID-JCP13>3.0.CO;2-6
Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: Effects of dexamethasone and IL-1α
resolves10.1093/jnci/83.11.775
Tumor Cell Invasion Inhibited by TIMP-2
resolves10.1182/blood.V99.10.3838
Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli
resolves10.4049/jimmunol.0903143
Mesenchymal Stem Cells Protect Breast Cancer Cells through Regulatory T Cells: Role of Mesenchymal Stem Cell-Derived TGF-β
resolves10.1172/JCI29713
Evidence for tissue-resident mesenchymal stem cells in human adult lung from studies of transplanted allografts
resolves10.1016/j.stem.2007.11.014
Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide
resolves10.1182/blood-2003-11-3909
Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase–mediated tryptophan degradation
resolves10.1084/jem.20020121
Tryptophan-derived Catabolites Are Responsible for Inhibition of T and Natural Killer Cell Proliferation Induced by Indoleamine 2,3-Dioxygenase
resolves10.1182/blood-2007-02-074997
Mesenchymal stem cells inhibit natural killer–cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2
resolves10.1182/blood-2010-02-270777
Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells
resolves10.1634/stemcells.2007-0554
Human Leukocyte Antigen-G5 Secretion by Human Mesenchymal Stem Cells Is Required to Suppress T Lymphocyte and Natural Killer Function and to Induce CD4+CD25highFOXP3+ Regulatory T Cells
resolves10.1182/blood-2006-06-028704
Toll-like receptors and their ligands control mesenchymal stem cell functions
resolves10.1634/stemcells.2007-0454
Toll-Like Receptors 3 and 4 Are Expressed by Human Bone Marrow-Derived Mesenchymal Stem Cells and Can Inhibit Their T-Cell Modulatory Activity by Impairing Notch Signaling
resolves10.1634/stemcells.2007-0563
Toll-Like Receptors on Human Mesenchymal Stem Cells Drive Their Migration and Immunomodulating Responses
resolves10.1182/blood-2005-07-2775
Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation
resolves10.1073/pnas.1431057100
Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G
resolves10.1096/fj.09-135194
ILT2/HLA‐G interaction impairs NK‐cell functions through the inhibition of the late but not the early events of the NK‐cell activating synapse
resolves10.1161/CIRCULATIONAHA.110.955971
Differentiation of Allogeneic Mesenchymal Stem Cells Induces Immunogenicity and Limits Their Long-Term Benefits for Myocardial Repair
resolves10.1016/j.exphem.2008.06.008
MHC expression kinetics and immunogenicity of mesenchymal stromal cells after short-term IFN-γ challenge
resolves10.1089/dna.2005.24.458
Effects of Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells on T and B Lymphocytes from BXSB Mice
resolves10.1016/j.exger.2009.07.006
Rejuvenation in distinct cell populations – What does it mean?
resolves10.1093/nar/gkp857
Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs
resolves10.1038/nature06487
Endogenous human microRNAs that suppress breast cancer metastasis
resolves10.1002/stem.467
Epithelial-Mesenchymal Transition-Derived Cells Exhibit Multilineage Differentiation Potential Similar to Mesenchymal Stem Cells  
resolves10.1186/1756-9966-28-127
Characterization of human breast cancer epithelial cells (HBCEC) derived from long term cultured biopsies
resolves10.1038/nature06188
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
resolves10.1515/BC.2009.050
Retrodifferentiation – a mechanism for cellular regeneration?
The 19 references without a DOI — listed, not checked
no DOI — not checkedFriedenstein AJ, Gorskaja JF, Kulagina NN: Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol. 1976, 4: 267-274.
no DOI — not checkedCao C, Dong Y: Study on culture and in vitro osteogenesis of blood-derived human mesenchymal stem cells. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2005, 19: 642-647.
no DOI — not checkedKitagawa YKM, Toriyama K, Kamei Y, Torii S: History of discovery of human adipose-derived stem cells and their clinical applications. Jpn J Plast Reconstr Surg. 2006, 49: 1097-1104.
no DOI — not checkedWolbank S, van Griensven M, Grillari-Voglauer R, Peterbauer-Scherb A: Alternative sources of adult stem cells: human amniotic membrane. Adv Biochem Eng Biotechnol. 2010, 123: 1-27.
no DOI — not checkedLu LL, Liu YJ, Yang SG, Zhao QJ, Wang X, Gong W, Han ZB, Xu ZS, Lu YX, Liu D, Chen ZZ, Han ZC: Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica. 2006, 91: 1017-1026.
no DOI — not checkedConconi MT, Burra P, Di Liddo R, Calore C, Turetta M, Bellini S, Bo P, Nussdorfer GG, Parnigotto PP: CD105 (SH2)(+) cells from Wharton's jelly show in vitro and in vivo myogenic differentiative potential. Int J Mol Med. 2006, 18: 1089-1096.
no DOI — not checkedLu LL, Song YP, Wei XD, Fang BJ, Zhang YL, Li YF: Comparative characterization of mesenchymal stem cells from human umbilical cord tissue and bone marrow. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008, 16: 140-146.
no DOI — not checkedMoretti P, Hatlapatka T, Marten D, Lavrentieva A, Majore I, Hass R, Kasper C: Mesenchymal stromal cells derived from human umbilical cord tissues: primitive cells with potential for clinical and tissue engineering applications. Advances in Biochemical Engineering/Biotechnology. 2010, 123: 29-54.
no DOI — not checkedCasiraghi F, Noris M, Remuzzi G: Immunomodulatory effects of mesenchymal stromal cells in solid organ transplantation. Current opinion in organ transplantation. 2010,
no DOI — not checkedMaccario R, Podesta M, Moretta A, Cometa A, Comoli P, Montagna D, Daudt L, Ibatici A, Piaggio G, Pozzi S, Frassoni F, Locatelli F: Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype. Haematologica. 2005, 90: 516-525.
no DOI — not checkedDeuse T, Stubbendorff M, Tang-Quan K, Phillips N, Kay MA, Eiermann T, Phan TT, Volk HD, Reichenspurner H, Robbins RC, Schrepfer S: Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells. Cell Transplant. 2010,
no DOI — not checkedCorcione A, Benvenuto F, Ferretti E, Giunti D, Cappiello V, Cazzanti F, Risso M, Gualandi F, Mancardi GL, Pistoia V, Uccelli A: Human mesenchymal stem cells modulate B-cell functions. Blood. 2006, United States, 107: 367-372. 10.1182/blood-2005-07-2657.
no DOI — not checkedRasmusson I, Le Blanc K, Sundberg B, Ringden O: Mesenchymal stem cells stimulate antibody secretion in human B cells. Scand J Immunol. 2007, England, 65: 336-343. 10.1111/j.1365-3083.2007.01905.x.
no DOI — not checkedTraggiai E, Volpi S, Schena F, Gattorno M, Ferlito F, Moretta L, Martini A: Bone marrow-derived mesenchymal stem cells induce both polyclonal expansion and differentiation of B cells isolated from healthy donors and systemic lupus erythematosus patients. Stem Cells. 2008, United States, 26: 562-569. 10.1634/stemcells.2007-0528.
no DOI — not checkedTomé M, López-Romero P, Albo C, Sepúlveda JC, Fernández-Gutiérrez B, Dopazo A, Bernad A, González MA: miR-335 orchestrates cell proliferation, migration and differentiation in human mesenchymal stem cells. Cell Death Differ. 2010,
no DOI — not checkedGuo L, Zhao RC, Wu Y: The role of microRNAs in self-renewal and differentiation of mesenchymal stem cells. Exp Hematol. 2011,
no DOI — not checkedDe Giorgi U, Cohen EN, Gao H, Mego M, Lee BN, Lodhi A, Cristofanilli M, Lucci A, Reuben JM: Mesenchymal stem cells expressing GD2 and CD271 correlate with breast cancer-initiating cells in bone marrow. Cancer Biol Ther. 2011,
no DOI — not checkedChaturvedi S, Hass R: Extracellular signals in young and aging breast epithelial cells and possible connections to age-associated breast cancer development. Mech Aging Dev. 2011,
no DOI — not checkedGruenloh W, Kambal A, Sondergaard C, McGee J, Nacey C, Kalomoiris S, Pepper K, Olson S, Fierro F, Nolta JA: Characterization and In Vivo Testing of Mesenchymal Stem Cells Derived from Human Embryonic Stem Cells. Tissue Eng Part A. 2011,
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1186/1478-811x-9-12"><img src="https://citestamp.com/citestamped/10.1186/1478-811x-9-12/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1186/1478-811x-9-12/badge.svg)](https://citestamp.com/citestamped/10.1186/1478-811x-9-12)